HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ishimaru, N. Articles by Hayashi, Y. Search for Related Content PubMed PubMed Citation Articles by Ishimaru, N. Articles by Hayashi, Y.

Possible Role of Organ-Specific Autoantigen for Fas Ligand-Mediated Activation-Induced Cell Death in Murine Sjögren’s Syndrome¹

Naozumi Ishimaru^*, Kumiko Yanagi^*, Kouichi Ogawa^*, Takashi Suda, Ichiro Saito^* and Yoshio Hayashi^2,*

^* Department of Pathology, Tokushima University School of Dentistry, Tokushima, Japan; and Center for the Development of Molecular Target Drugs, Cancer Research Institute, Kanazawa University, Ishikawa, Japan

Activation-induced cell death (AICD) is a well-known mechanism of peripheral T cell tolerance that depends upon an interaction between Fas and Fas ligand (FasL). In this study, we demonstrate that the administration of a soluble form of anti-FasL Ab, FLIM58, results in severe destructive autoimmune exocrinopathy in the murine model of human Sjögren’s syndrome (SS), and we found that an organ-specific autoantigen may play an important role on down-modulation of AICD. A high titer of serum autoantibodies against 120-kDa -fodrin autoantigen was detected in the FLIM58-treated mice, and splenic T cell culture supernatants contained high levels of IFN-. In vitro T cell apoptosis assay indicated that FasL-mediated AICD is down-regulated by autoantigen stimulation in spleen cells from the murine SS model, but not from Fas-deficient MRL/lpr mice and FasL-deficient MRL/gld mice. FasL undergo metalloproteinase-mediated proteolytic processing in their extracellular domains, resulting in the release of soluble trimeric ligands (soluble FasL). We showed that the processing of soluble FasL occurs in autoantigen-specific CD4⁺ T cells, and that a significant increase in expressions of metalloproteinase-9 mRNA was observed in spleen cells from SS model mice. These findings indicate that the increased generation of soluble FasL inhibits the normal AICD process, leading to the proliferation of effector CD4⁺ T cells in the murine SS model.

This article has been cited by other articles:

				T. Izawa, N. Ishimaru, K. Moriyama, M. Kohashi, R. Arakaki, and Y. Hayashi Crosstalk between RANKL and Fas signaling in dendritic cells controls immune tolerance Blood, July 1, 2007; 110(1): 242 - 250. [Abstract] [Full Text] [PDF]

				G. Gannot, M. A. Tangrea, J. W. Gillespie, H. S. Erickson, B. S. Wallis, R. A. Leakan, V. Knezevic, D. P. Hartmann, R. F. Chuaqui, and M. R. Emmert-Buck Layered Peptide Arrays: High-Throughput Antibody Screening of Clinical Samples J. Mol. Diagn., October 1, 2005; 7(4): 427 - 436. [Abstract] [Full Text] [PDF]

				K. Miyazaki, N. Takeda, N. Ishimaru, F. Omotehara, R. Arakaki, and Y. Hayashi Analysis of in Vivo Role of {alpha}-Fodrin Autoantigen in Primary Sjogren's Syndrome Am. J. Pathol., October 1, 2005; 167(4): 1051 - 1059. [Abstract] [Full Text] [PDF]